| 30021200.23 |
Antiserum and other blood containing human genetic resources |
kilogram/- |
20% |
ABV |
P.V/Q.W |
-- |
| 30021200.30 |
Erythropoietin(EPO) |
kilogram/- |
20% |
ABR |
P.V/Q.W |
Compare-30021200.23 |
| 30021200.93 |
Rare disease drug preparations. |
kilogram/- |
20% |
AB |
P.V/Q.W |
Compare-30021200.30 |
| 30021200.94 |
Other antiserum and blood containing endangered animal components |
kilogram/- |
20% |
ABEF |
P.V/Q.W |
Compare-30021200.93 |
| 30021200.99 |
Other anti-serum and other blood types due to the resolution of anti-cancer drugs |
kilogram/- |
20% |
AB |
P.V/Q.W |
Compare-30021200.94 |
| 30021300.10 |
Non-mixed immune products listed in the Doping Catalogue are not prepared with fixed dose or made into retail packaging |
kilogram/- |
20% |
ABL |
P.V/Q.W |
Compare-30021200.99 |
| 30021300.90 |
Other non-mixed immune products,not prepared in a fixed dose or in retail packaging |
kilogram/- |
20% |
AB |
P.V/Q.W |
Compare-30021300.10 |
| 30021400.00 |
Mixed immune products,not given in doses or in retail packages |
kilogram/- |
20% |
AB |
P.V/Q.W |
Compare-30021300.90 |
| 30021500.10 |
Anti-anti-cancer drug preparation (excluding cancer adjuvant treatment drugs) |
kilogram/- |
20% |
AB |
P.V/Q.W |
Compare-30021400.00 |
| 30021500.30 |
Rare disease drug preparations. |
kilogram/- |
20% |
AB |
P.V/Q.W |
Compare-30021500.10 |
| 30021500.40 |
Veterinary immunology in vivo diagnostic products (dosed) |
kilogram/- |
20% |
ABR |
P.V/Q.W |
Compare-30021500.30 |
| 30021500.50 |
Immune products listed in the Doping Catalogue have been prepared with a fixed dose or made into retail packaging |
kilogram/- |
20% |
ABL |
P.V/Q.W |
Compare-30021500.40 |
| 30021500.90 |
Other immunological products,which have been dosed or made into retail packaging for the purpose of splitting the anti-cancer drug |
kilogram/- |
20% |
AB |
P.V/Q.W |
Compare-30021500.50 |
| 30024100.11 |
The novel coronavirus (COVID-19) vaccine has been dosed or made into retail packaging |
kilogram/- |
20% |
QAB |
V/W |
Compare-30021500.90 |
| 30024100.19 |
Novel coronavirus (COVID-19) vaccine,not dosed or made into retail packaging |
kilogram/- |
20% |
QAB |
V/W |
Compare-30024100.11 |
| 30024100.90 |
Other human vaccines |
kilogram/- |
20% |
QAB |
V/W |
Compare-30024100.19 |
| 30024200.00 |
Veterinary vaccine |
kilogram/- |
20% |
R |
|
Compare-30024100.90 |
| 30024920.00 |
Ricin |
kilogram/- |
20% |
23Q |
|
Compare-30024200.00 |
| 30024930.10 |
Control of bacteria and viruses in dual-use items |
kilogram/piece |
20% |
3AB |
P.V/Q.W |
Compare-30024920.00 |
| 30024930.20 |
Bacillus thuringiensis,Bacillus subtilis |
kilogram/piece |
20% |
ABS |
P.V/Q.W |
Compare-30024930.10 |
htshub©